Details.
Advanced blood testing to identify gene mutations associated with a higher risk of developing gastrointestinal cancers, including Lynch syndrome, BRCA1 and BRCA2 mutations, polyposis syndromes, and CDH1 and CTNNA1 gene mutations. The team provides guidance on testing and risk management options.